HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved outcomes of outborn preterm infants if admitted to perinatal centers versus freestanding pediatric hospitals.

AbstractOBJECTIVES:
To examine whether admission hospital type (13 perinatal centers vs 4 freestanding pediatric hospitals) was associated with differences in risk and illness severity adjusted mortality and morbidity among outborn preterm infants.
STUDY DESIGN:
Records of singleton outborn infants < or =32 weeks' gestational age (n = 605) admitted to 17 tertiary level neonatal intensive care units participating in the Canadian Neonatal Network for the period 1996 to 1997 were examined.
RESULTS:
Outborn infants admitted to freestanding pediatric hospitals were at higher risk of death (adjusted odds ratio [AOR], 2.25; 95% confidence interval [CI], 1.20, 4.20), nosocomial infection (AOR, 2.48; 95% CI, 1.64, 3.73), and oxygen dependency at 28 days of age (AOR, 1.77; 95% CI, 1.14, 2.75) when compared with outborn infants admitted to perinatal centers.
CONCLUSIONS:
After adjustment for perinatal risks and admission illness severity, outborn infants had better outcomes if they were admitted to perinatal centers compared with freestanding pediatric hospitals.
AuthorsPrakesh S Shah, Vibhuti Shah, Zhenguo Qiu, Arne Ohlsson, Shoo K Lee, Canadian Neonatal Network
JournalThe Journal of pediatrics (J Pediatr) Vol. 146 Issue 5 Pg. 626-31 (May 2005) ISSN: 0022-3476 [Print] United States
PMID15870665 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Apgar Score
  • Canada (epidemiology)
  • Cross Infection (epidemiology)
  • Databases, Factual
  • Female
  • Gestational Age
  • Hospitals, Pediatric
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases (epidemiology, mortality)
  • Infant, Premature
  • Intensive Care Units, Neonatal
  • Male
  • Severity of Illness Index
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: